» Articles » PMID: 35463717

Genetic Screening in Heritable Thoracic Aortic Disease-rationale, Potentials and Pitfalls

Overview
Publisher Springer
Date 2022 Apr 25
PMID 35463717
Authors
Affiliations
Soon will be listed here.
Abstract

Thoracic aortic aneurysms are silent yet deadly clinical entities which may elude detection until an acutely life-threatening aortic dissection or rupture occurs. Approximately 20% of patients with thoracic aortic aneurysms or dissection have a positive family history, indicating a strong genetic component to the aetiology. Genetic screening in such hereditary thoracic aortic disease (HTAD) may thus be beneficial in detecting causative genetic mutations in affected patients, identifying asymptomatic family members who may be at risk, and in guiding the optimal timing of preventative surgery in those with confirmed genetic aortopathy. Genetic screening can facilitate personalised aortic care tailored to an individual's specific genetic abnormality, with the aim of mitigating the significant morbidity burden and premature mortality associated with HTAD. This review examines the rationale for genetic screening in HTAD, its potential applications, current limitations and potential future directions.

Citing Articles

Trends and disparities in age, sex, ethnoracial background, and urbanization status in adult mortality due to thoracic aortic aneurysm: a retrospective nationwide study in the United States.

Goyal A, Saeed H, Shamim U, Siddiqui M, Abdullah , Arshad M Int J Surg. 2025; 110(12):7647-7655.

PMID: 39806735 PMC: 11634109. DOI: 10.1097/JS9.0000000000002150.


Identification of Genetic Variants Associated with Hereditary Thoracic Aortic Diseases (HTADs) Using Next Generation Sequencing (NGS) Technology and Genotype-Phenotype Correlations.

Butnariu L, Russu G, Luca A, Sandu C, Trandafir L, Vasiliu I Int J Mol Sci. 2024; 25(20).

PMID: 39456956 PMC: 11508433. DOI: 10.3390/ijms252011173.


Contributions of Germline and Somatic Mosaic Genetics to Thoracic Aortic Aneurysms in Nonsyndromic Individuals.

Chen M, Deng E, Yamada J, Choudhury S, Scotellaro J, Kelley L J Am Heart Assoc. 2024; 13(14):e033232.

PMID: 38958128 PMC: 11292778. DOI: 10.1161/JAHA.123.033232.


Unraveling the Enigma of Aortic Dissection: From Genetics to Innovative Therapies.

Godugu S, Sinha T, Pradeepan M, Eze-Odurukwe A, Bokhari S, Islam R Cureus. 2024; 16(4):e57803.

PMID: 38721226 PMC: 11077317. DOI: 10.7759/cureus.57803.


Practice Patterns and Barriers to Vascular Genetic Testing Among Vascular Surgeons.

Dittman J, Prakash S, Gupta P, Wiszniewski W, Singh N, Smeds M Ann Vasc Surg. 2024; 105:140-149.

PMID: 38599485 PMC: 11189730. DOI: 10.1016/j.avsg.2024.01.032.


References
1.
Loeys B, Schwarze U, Holm T, Callewaert B, Thomas G, Pannu H . Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006; 355(8):788-98. DOI: 10.1056/NEJMoa055695. View

2.
Renard M, Francis C, Ghosh R, Scott A, Witmer P, Ades L . Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection. J Am Coll Cardiol. 2018; 72(6):605-615. PMC: 6378369. DOI: 10.1016/j.jacc.2018.04.089. View

3.
Chou A, Ma W, Mok S, Ziganshin B, Peterss S, Rizzo J . Do Familial Aortic Dissections Tend to Occur at the Same Age?. Ann Thorac Surg. 2016; 103(2):546-550. DOI: 10.1016/j.athoracsur.2016.06.007. View

4.
Stheneur C, Collod-Beroud G, Faivre L, Buyck J, Gouya L, Le Parc J . Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene. Eur J Hum Genet. 2009; 17(9):1121-8. PMC: 2986588. DOI: 10.1038/ejhg.2009.36. View

5.
Campens L, Renard M, Callewaert B, Coucke P, De Backer J, De Paepe A . New insights into the molecular diagnosis and management of heritable thoracic aortic aneurysms and dissections. Pol Arch Med Wewn. 2013; 123(12):693-700. DOI: 10.20452/pamw.2015. View